Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

CompletedOBSERVATIONAL
Enrollment

308

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
AnaemiaChronic Kidney Disease (CKD)
Trial Locations (40)

1220

Research Site, Vienna

1431

Research Site, Sofia

1612

Research Site, Sofia

3000

Research Site, Vratsa

3400

Research Site, Montana

4000

Research Site, Plovdiv

4002

Research Site, Plovdiv

4003

Research Site, Plovdiv

4020

Research Site, Linz

4400

Research Site, Pazardzhik

6000

Research Site, Kecskemét

6500

Research Site, Baja

6724

Research Site, Szeged

6807

Research Site, Feldkirch

7900

Research Site, Szigetvár

8900

Research Site, Zalaegerszeg

9000

Research Site, Varna

9300

Research Site, Dobrich

9700

Research Site, Szombathely

10676

Research Site, Athens

12462

Research Site, Athens

14004

Research Site, Córdoba

26500

Research Site, Pátrai

46010

Research Site, Valencia

46017

Research Site, Valencia

54642

Research Site, Thessaloniki

56429

Research Site, Thessaloniki

625 00

Research Site, Brno

580 22

Research Site, Havlíčkův Brod

592 31

Research Site, Nové Město na Moravě

674 35

Research Site, Třebíč

00041

Research Site, Albano Laziale RM

92-213

Research Site, Lodz

93-338

Research Site, Lodz

20-718

Research Site, Lublin

60-355

Research Site, Poznan

98-200

Research Site, Sieradz

37-450

Research Site, Stalowa Wola

08916

Research Site, Badalona

08035

Research Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY